Status
Conditions
Treatments
About
Full description
3.Patients and methods
Study design:
Case Control study two groups (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion)
Study location:
the study will be conducted in Assiut university hospitals (women's health hospital) .
Study duration:
the study will be carried out from October 2025 till October 2026.
Sample size :
the calculated sample size for two groups 100 cases (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion).
4.Inclusion criteria
All woman with repeated abortion of Unknwon cause.
Not received H.pylori eradication therapy in prior 3 months .
5.Exclusion criteria
Known uterine anatomical causes of abortion.
Current systemic antibiotic use and PPIs within 2 weeks.
Medical diseases as (Thyroid disorders , DM,HTN).
Antiphspholipid syndrome. 6.Methods
Case Control study at Assiut woman's heath hospital from October 2025 till October 2026.
Case Control study two groups (one group of women with history of recurrent abortion and another group of women without recurrent of abortion) by stool antigen test.
7.All patients will be subjected to the following
Complete obstetric history , medical history, smoking ,alcohol, recent antibiotics ,PPIs , socioeconomic status
Laboratory samples :
H.pylori antigen in stool ,complete blood count , abdominopelvic ultrasound , urine analysis , liver and kidney function tests ,TSH , prolactin and any necessary investigation will be done.
Anti cardiolipin (IgM , IgG) ,Lupus anti coagulant and Anti B2 glycoproteinA1 (IgM, IgG) and 3D US on uterus . 8.Ethical considerations
All subjects will provide written informed consent to participate in the study .
The protocol of the study will be presented to the local ethics committee for approval.
9.Statistical analysis
Statistical analysis will be performed using Spss version 23.
10.References
1. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 205-214
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186
3. Chen MJ, Fang YJ, Wu MS, Chen CC, Chen YN, Yu CC et al. Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan. 2020;35:233-40
4. Ambühl LM, Baandrup U, Dybkær K,Blaakær J, Uldbjerg N, Sørensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery 2016;2016.
5. Azami M, Nasirkandy MP, Mansouri A, Darvishi Z, Rahmati S, Abangah G, DehghanHR, Borji M, Abbasalizadeh S. GGollobal Prevelance of H.pylori infection in pregnant women: a systematic review and meta-analysis study. Int J Women's Health Reprod Sci. 2017;5:30-6.
6. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013 99:63.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria• All woman with repeated abortion of Unknwon cause.
Exclusion Criteria:
100 participants in 1 patient group
Loading...
Central trial contact
Hanan Mohamed Nafeh assiut; Mostafa Gamal Ahmed Mostafa موشا -مركز اسيوط -محافظة اسيوط
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal